Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]

Anna Stępień; Krzysztof Jamroziak; Tomasz Sacha; Dorota Link-Lenczowska; Izabela Florek; Witold Prejzner; Zofia Specht-Szwoch; Małgorzata Całbecka; Marcin Rymko; Marek Dudziński; Paulina Wieszczy; Krzysztof Warzocha; Joanna Góra-Tybor

doi:10.1016/j.achaem.2016.11.001

Acta Haematologica Polonica
Vol 47, No 4 (2016) Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]

Vol 47, No 4 (2016)

Errata / Erratum

Published online: 2016-10-01

View PDF (Polish) Download PDF file

Page views 190

Article views/downloads 198

Get Citation

Connect on Social Media

Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]

Anna Stępień, Krzysztof Jamroziak, Tomasz Sacha, Dorota Link-Lenczowska, Izabela Florek, Witold Prejzner, Zofia Specht-Szwoch, Małgorzata Całbecka, Marcin Rymko, Marek Dudziński, Paulina Wieszczy, Krzysztof Warzocha, Joanna Góra-Tybor

DOI: 10.1016/j.achaem.2016.11.001

Acta Haematol Pol 2016;47(4):263.

Abstract

Not available

Article available in PDF format

View PDF (Polish) Download PDF file

Connect on Social Media

Connect on Social Media

E-mail alerts

Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]

Abstract

Article available in PDF format